Emily Milarachi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Emily Milarachi has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- David Goldenberg
Department of Otolaryngology- Head and Neck Surgery, The Pennsylvania State University College of Medicine and Penn State Milton S. Hershey Medical Center, Hershey, PA, United States
9 shared publications - Cesar Aliaga
Department of Biochemistry and Molecular Biology, Pennsylvania State University, College of Medicine, Hershey, Pennsylvania
8 shared publications - Christopher C. Tseng
Department of Otolaryngology–Head and Neck Surgery Rutgers New Jersey Medical School Newark New Jersey U.S.A.
8 shared publications - Craig Meyers
Department of Microbiology and Immunology, The Pennsylvania State University College of Medicine, Hershey, PA 17033, USA
8 shared publications - David Goldrich
Department of Otolaryngology–Head and Neck Surgery Penn State Milton S. Hershey Medical Center and Penn State College of Medicine Hershey 17033 Pennsylvania USA
8 shared publications - James Riley Broach
Department of Molecular and Precision Medicine, Penn State College of Medicine, Hershey, Pennsylvania, USA
8 shared publications
Latest Publications
- Open Access
Mental Health and Sleep Outcomes Among Patients Diagnosed With Chronic Cough
Objective: Chronic cough is a complex, multi‐factorial condition. Past studies have associated chronic cough with a degraded quality of life, namely related to psychological and sleep outcomes. We investigated the association between chronic cough and later diagnosis with mental health and sleep disorders using a large database. Study Design: Cross‐sectional study. Setting: TriNetX research database. Methods: A retrospective cohort analysis was conducted using the TriNetX research database. Patients aged ≥18 years with chronic cough diagnosed from 2008 to 2018 and no recent history of mental health or sleep disorders were included and compared to a matched control cohort. Primary outcomes were 5‐year diagnoses with sleep disorders, depression, and anxiety. Secondary outcomes included rates of interaction with the healthcare system, other mental health diagnoses, and usage of psychological medications and sleep devices. Results: Of 65,442 included patients with chronic cough, mean age was 54.5 ± 15.3 and patients were 60.8% female, 75.2% white, and 86.5% not Hispanic/Latino. After demographic matching, patients with chronic cough had significantly higher rates of smoking, obesity, asthma, and GERD. Patients were at significantly higher risks of developing sleep disorders (RR 1.58, P < .01), mental health diagnoses (RR 1.33, P < .01), and receiving anti‐reflux, antidepressant, and CPAP treatments ( P < .01 for all). Conclusion: Chronic cough diagnosis is associated with increased risk of later development of anxiety, depression, and disordered sleep. This is the largest study to date examining the burden of chronic cough alongside associated outcomes. Future studies will further investigate these associations and investigate improved patient care models.
Open AccessMental Health and Sleep Outcomes Among Patients Diagnosed With Chronic Cough
Objective: Chronic cough is a complex, multi‐factorial condition. Past studies have associated chronic cough with a degraded quality of life, namely related to psychological and sleep outcomes. We investigated the association between chronic cough and later diagnosis with mental health and sleep disorders using a large database. Study Design: Cross‐sectional study. Setting: TriNetX research database. Methods: A retrospective cohort analysis was conducted using the TriNetX research database. Patients aged ≥18 years with chronic cough diagnosed from 2008 to 2018 and no recent history of mental health or sleep disorders were included and compared to a matched control cohort. Primary outcomes were 5‐year diagnoses with sleep disorders, depression, and anxiety. Secondary outcomes included rates of interaction with the healthcare system, other mental health diagnoses, and usage of psychological medications and sleep devices. Results: Of 65,442 included patients with chronic cough, mean age was 54.5 ± 15.3 and patients were 60.8% female, 75.2% white, and 86.5% not Hispanic/Latino. After demographic matching, patients with chronic cough had significantly higher rates of smoking, obesity, asthma, and GERD. Patients were at significantly higher risks of developing sleep disorders (RR 1.58, P < .01), mental health diagnoses (RR 1.33, P < .01), and receiving anti‐reflux, antidepressant, and CPAP treatments ( P < .01 for all). Conclusion: Chronic cough diagnosis is associated with increased risk of later development of anxiety, depression, and disordered sleep. This is the largest study to date examining the burden of chronic cough alongside associated outcomes. Future studies will further investigate these associations and investigate improved patient care models.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Genome Instability Precedes Viral Integration in Human Papillomavirus–Transformed Tonsillar Keratinocytes
Table S1. Specifications for thermocycler settings for Anchored PCR.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Genome Instability Precedes Viral Integration in Human Papillomavirus–Transformed Tonsillar Keratinocytes
Table S1. Specifications for thermocycler settings for Anchored PCR.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from Genome Instability Precedes Viral Integration in Human Papillomavirus–Transformed Tonsillar Keratinocytes
Figure S2. WGS and anchored PCR analysis of chromosomal region adjacent to viral integration sites in transformed keratinocytes.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from Genome Instability Precedes Viral Integration in Human Papillomavirus–Transformed Tonsillar Keratinocytes
Figure S2. WGS and anchored PCR analysis of chromosomal region adjacent to viral integration sites in transformed keratinocytes.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Genome Instability Precedes Viral Integration in Human Papillomavirus–Transformed Tonsillar Keratinocytes
Figure S1. Long Range Anchored PCR
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Genome Instability Precedes Viral Integration in Human Papillomavirus–Transformed Tonsillar Keratinocytes
Figure S1. Long Range Anchored PCR
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Data from Genome Instability Precedes Viral Integration in Human Papillomavirus–Transformed Tonsillar Keratinocytes
Approximately 70% of oropharyngeal squamous carcinomas (OPSCC) are associated with human papillomavirus (HPV). Although patients with HPV-positive (HPV+) tumors generally have better outcomes than those with HPV-negative tumors, a subset of HPV+ positive patients do have poor outcomes. Our previous work suggested that tumors with integrated virus exhibit significantly greater genome-wide genomic instability than those with only episomal viral genomes, and patients with HPV+ OPSCC with episomal viral genomes had better outcomes. To explore the causal relation between viral integration and genomic instability, we have examined the time course of viral integration and genetic instability in tonsillar keratinocytes transformed with HPV16. HPV-infected human tonsil keratinocyte cell lines were continuously passaged, and every fifth passage, some cells were retained for genomic analysis. Whole-genome sequencing and optical genomic mapping confirmed that virus integrated in five of six cell lines while remaining episomal in the sixth. In all lines, genome instability occurred during early passages but essentially ceased following viral integration; however, it continued to occur in later passages in the episomal line. To test tumorigenicity of the cell lines, cells were injected subcutaneously into the flanks of nude mice. A cell line with the integrated virus induced tumors following injection in the nude mouse whereas that with the episomal virus did not.Implications:Genomic instability in HPV OPSCC tumors is not the result of viral integration but likely promotes integration. Moreover, transformants with episomal virus seem to be less tumorigenic than those with integrated virus.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Genome Instability Precedes Viral Integration in Human Papillomavirus–Transformed Tonsillar Keratinocytes
Approximately 70% of oropharyngeal squamous carcinomas (OPSCC) are associated with human papillomavirus (HPV). Although patients with HPV-positive (HPV+) tumors generally have better outcomes than those with HPV-negative tumors, a subset of HPV+ positive patients do have poor outcomes. Our previous work suggested that tumors with integrated virus exhibit significantly greater genome-wide genomic instability than those with only episomal viral genomes, and patients with HPV+ OPSCC with episomal viral genomes had better outcomes. To explore the causal relation between viral integration and genomic instability, we have examined the time course of viral integration and genetic instability in tonsillar keratinocytes transformed with HPV16. HPV-infected human tonsil keratinocyte cell lines were continuously passaged, and every fifth passage, some cells were retained for genomic analysis. Whole-genome sequencing and optical genomic mapping confirmed that virus integrated in five of six cell lines while remaining episomal in the sixth. In all lines, genome instability occurred during early passages but essentially ceased following viral integration; however, it continued to occur in later passages in the episomal line. To test tumorigenicity of the cell lines, cells were injected subcutaneously into the flanks of nude mice. A cell line with the integrated virus induced tumors following injection in the nude mouse whereas that with the episomal virus did not.Implications:Genomic instability in HPV OPSCC tumors is not the result of viral integration but likely promotes integration. Moreover, transformants with episomal virus seem to be less tumorigenic than those with integrated virus.
- Open Access
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Genome Instability Precedes Viral Integration in Human Papillomavirus–Transformed Tonsillar Keratinocytes
Table S1. Specifications for thermocycler settings for Anchored PCR.
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Genome Instability Precedes Viral Integration in Human Papillomavirus–Transformed Tonsillar Keratinocytes
Table S1. Specifications for thermocycler settings for Anchored PCR.
- Open Access
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from Genome Instability Precedes Viral Integration in Human Papillomavirus–Transformed Tonsillar Keratinocytes
Figure S2. WGS and anchored PCR analysis of chromosomal region adjacent to viral integration sites in transformed keratinocytes.
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from Genome Instability Precedes Viral Integration in Human Papillomavirus–Transformed Tonsillar Keratinocytes
Figure S2. WGS and anchored PCR analysis of chromosomal region adjacent to viral integration sites in transformed keratinocytes.
- Open Access
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Genome Instability Precedes Viral Integration in Human Papillomavirus–Transformed Tonsillar Keratinocytes
Figure S1. Long Range Anchored PCR
- 6 February 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Genome Instability Precedes Viral Integration in Human Papillomavirus–Transformed Tonsillar Keratinocytes
Figure S1. Long Range Anchored PCR
- Open Access
- 30 October 2024
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Research
- Vol. 23 (2) , 119-127
Genome Instability Precedes Viral Integration in Human Papillomavirus–Transformed Tonsillar Keratinocytes
Approximately 70% of oropharyngeal squamous carcinomas (OPSCC) are associated with human papillomavirus (HPV). Although patients with HPV-positive (HPV+) tumors generally have better outcomes than those with HPV-negative tumors, a subset of HPV+ positive patients do have poor outcomes. Our previous work suggested that tumors with integrated virus exhibit significantly greater genome-wide genomic instability than those with only episomal viral genomes, and patients with HPV+ OPSCC with episomal viral genomes had better outcomes. To explore the causal relation between viral integration and genomic instability, we have examined the time course of viral integration and genetic instability in tonsillar keratinocytes transformed with HPV16. HPV-infected human tonsil keratinocyte cell lines were continuously passaged, and every fifth passage, some cells were retained for genomic analysis. Whole-genome sequencing and optical genomic mapping confirmed that virus integrated in five of six cell lines while remaining episomal in the sixth. In all lines, genome instability occurred during early passages but essentially ceased following viral integration; however, it continued to occur in later passages in the episomal line. To test tumorigenicity of the cell lines, cells were injected subcutaneously into the flanks of nude mice. A cell line with the integrated virus induced tumors following injection in the nude mouse whereas that with the episomal virus did not. Implications: Genomic instability in HPV OPSCC tumors is not the result of viral integration but likely promotes integration. Moreover, transformants with episomal virus seem to be less tumorigenic than those with integrated virus.
- 30 October 2024
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Research
- Vol. 23 (2) , 119-127
Open AccessGenome Instability Precedes Viral Integration in Human Papillomavirus–Transformed Tonsillar Keratinocytes
Approximately 70% of oropharyngeal squamous carcinomas (OPSCC) are associated with human papillomavirus (HPV). Although patients with HPV-positive (HPV+) tumors generally have better outcomes than those with HPV-negative tumors, a subset of HPV+ positive patients do have poor outcomes. Our previous work suggested that tumors with integrated virus exhibit significantly greater genome-wide genomic instability than those with only episomal viral genomes, and patients with HPV+ OPSCC with episomal viral genomes had better outcomes. To explore the causal relation between viral integration and genomic instability, we have examined the time course of viral integration and genetic instability in tonsillar keratinocytes transformed with HPV16. HPV-infected human tonsil keratinocyte cell lines were continuously passaged, and every fifth passage, some cells were retained for genomic analysis. Whole-genome sequencing and optical genomic mapping confirmed that virus integrated in five of six cell lines while remaining episomal in the sixth. In all lines, genome instability occurred during early passages but essentially ceased following viral integration; however, it continued to occur in later passages in the episomal line. To test tumorigenicity of the cell lines, cells were injected subcutaneously into the flanks of nude mice. A cell line with the integrated virus induced tumors following injection in the nude mouse whereas that with the episomal virus did not. Implications: Genomic instability in HPV OPSCC tumors is not the result of viral integration but likely promotes integration. Moreover, transformants with episomal virus seem to be less tumorigenic than those with integrated virus.
- 11 November 2022
- Published by SAGE Publications in Thyroid®
- Vol. 32 (11) , 1382-1391
Hypocalcemia After Thyroidectomy in Patients with Prior Bariatric Surgery: A Propensity Score Matched Analysis from a National Administrative Database
Background: Studies have suggested that patients with prior gastric bypass may be at increased risk for hypocalcemia following thyroidectomy. Unfortunately, most of these studies are limited to case reports and small series. This study represents the largest sample size to date to assess the incidence of post-thyroidectomy hypocalcemia in patients with a history of bariatric surgery. Methods: The TriNetX Research Network was queried to retrospectively identify patients with prior bariatric surgery who underwent total thyroidectomy between 2011 and 2021. The incidence of hypocalcemia following surgery was compared with patients who underwent total thyroidectomy, and hemithyroidectomy with no history of bariatric surgery. Results: We identified 446 patients with a history of bariatric surgery and subsequent thyroidectomy, 29,346 patients with total thyroidectomy, and 19,603 patients with hemithyroidectomy alone. The one-month incidence of hypocalcemia was 54.7% in those with a history of bariatric surgery who underwent thyroidectomy, 43.9% in those with thyroidectomy alone (relative risk, RR = 1.2 [confidence interval, CI 1.1–1.4], p < 0.001), and 8.1% in those with hemithyroidectomy only (RR = 6.8 [CI 6.1–7.4], p < 0.001). Permanent hypocalcemia was documented in 11.4% of patients with prior bariatric surgery who underwent thyroidectomy, 7.7% of those with thyroidectomy only (RR = 1.5 [CI 1.1–1.9], p = 0.003), and 2.9% of patients with hemithyroidectomy alone (RR = 3.9 [CI 3.0–5.2], p < 0.001). Significant differences persisted after matching demographics, prior need for supplementation, and risk factors for hypocalcemia after thyroidectomy. When stratified by bariatric procedure, patients with a history of Roux-en-Y gastric bypass (RYGB) ( n = 35) had a greater, although not statistically significant, risk of short-term hypocalcemia (51.4%; RR = 1.2 [CI 0.8–1.6], p = 0.37), and a significantly increased risk of permanent hypocalcemia (20.0%; RR = 2.6 [CI 1.3–5.1], p = 0.005) compared with thyroidectomy alone. Sleeve gastrectomy (SG) ( n = 40) was not associated with an increased risk of short-term (40.0%; RR = 0.9 [CI 0.6–1.3], p = 0.62) or permanent (7.5%; RR = 1.0 [CI 0.3–2.9], p = 0.96) hypocalcemia. Conclusions: Prior RYGB, but not SG, may increase the risk of permanent hypocalcemia after thyroidectomy. Additional research is necessary to determine optimal prevention and treatment strategies to reduce morbidity in this population.
- 11 November 2022
- Published by SAGE Publications in Thyroid®
- Vol. 32 (11) , 1382-1391
Hypocalcemia After Thyroidectomy in Patients with Prior Bariatric Surgery: A Propensity Score Matched Analysis from a National Administrative Database
Background: Studies have suggested that patients with prior gastric bypass may be at increased risk for hypocalcemia following thyroidectomy. Unfortunately, most of these studies are limited to case reports and small series. This study represents the largest sample size to date to assess the incidence of post-thyroidectomy hypocalcemia in patients with a history of bariatric surgery. Methods: The TriNetX Research Network was queried to retrospectively identify patients with prior bariatric surgery who underwent total thyroidectomy between 2011 and 2021. The incidence of hypocalcemia following surgery was compared with patients who underwent total thyroidectomy, and hemithyroidectomy with no history of bariatric surgery. Results: We identified 446 patients with a history of bariatric surgery and subsequent thyroidectomy, 29,346 patients with total thyroidectomy, and 19,603 patients with hemithyroidectomy alone. The one-month incidence of hypocalcemia was 54.7% in those with a history of bariatric surgery who underwent thyroidectomy, 43.9% in those with thyroidectomy alone (relative risk, RR = 1.2 [confidence interval, CI 1.1–1.4], p < 0.001), and 8.1% in those with hemithyroidectomy only (RR = 6.8 [CI 6.1–7.4], p < 0.001). Permanent hypocalcemia was documented in 11.4% of patients with prior bariatric surgery who underwent thyroidectomy, 7.7% of those with thyroidectomy only (RR = 1.5 [CI 1.1–1.9], p = 0.003), and 2.9% of patients with hemithyroidectomy alone (RR = 3.9 [CI 3.0–5.2], p < 0.001). Significant differences persisted after matching demographics, prior need for supplementation, and risk factors for hypocalcemia after thyroidectomy. When stratified by bariatric procedure, patients with a history of Roux-en-Y gastric bypass (RYGB) ( n = 35) had a greater, although not statistically significant, risk of short-term hypocalcemia (51.4%; RR = 1.2 [CI 0.8–1.6], p = 0.37), and a significantly increased risk of permanent hypocalcemia (20.0%; RR = 2.6 [CI 1.3–5.1], p = 0.005) compared with thyroidectomy alone. Sleeve gastrectomy (SG) ( n = 40) was not associated with an increased risk of short-term (40.0%; RR = 0.9 [CI 0.6–1.3], p = 0.62) or permanent (7.5%; RR = 1.0 [CI 0.3–2.9], p = 0.96) hypocalcemia. Conclusions: Prior RYGB, but not SG, may increase the risk of permanent hypocalcemia after thyroidectomy. Additional research is necessary to determine optimal prevention and treatment strategies to reduce morbidity in this population.